"RTOG 0424: Preliminary results of a phase II study of a temozolomide (TMZ) and radiotherapy (RT) in high risk low grade gliomas (LGGs)" by B. Fisher

Article

RTOG 0424: Preliminary results of a phase II study of a temozolomide (TMZ) and radiotherapy (RT) in high risk low grade gliomas (LGGs)

Canadian Journal of Neurological Sciences (2014)

B. Fisher, University of Western Ontario
C. Hu, Radiation Therapy Oncology Group
D. Macdonald, University of Western Ontario
G. Lesser
S. Coons, Barrow Neurological Institute
D. Brachman
S. Ryu, Ford Motor Company
M. Werner-Wasik, Thomas Jefferson University
J.P. Bahary, Université de Montréal
A. Chakravarti, Ohio State University
M. Mehta, University of Maryland, College Park

Link

Disciplines

Anesthesiology,
Medicine and Health Sciences and
Oncology

Publication Date

January 10, 2014

DOI

10.1017/cjn.2014.61

Citation Information

B. Fisher, C. Hu, D. Macdonald, G. Lesser, et al.. "RTOG 0424: Preliminary results of a phase II study of a temozolomide (TMZ) and radiotherapy (RT) in high risk low grade gliomas (LGGs)" Canadian Journal of Neurological Sciences Vol. 41 (2014)
Available at: http://works.bepress.com/minesh-mehta/192/